Gregory Gene Freitag insider trades: PDS Biotechnology (PDSB) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Gregory reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | PDSB | ↑ Buy | 15,060 | $1.66 | $25K | Direct | Mar 3, 2025 (3d) |
| Mar 7, 2024 | AXGN | ↓ Sell | 25,000 | $9.00 | $225K | Direct | Mar 8, 2024 (1d) |
| Jun 1, 2023 | AXGN | ↓ Sell | 41,980 | $8.71 | $366K | Direct | Jun 5, 2023 (4d) |
| May 23, 2023 | AXGN | ↓ Sell | 7,468 | $9.23 | $69K | Direct | May 24, 2023 (1d) |
| Nov 14, 2022 | AXGN | ↓ Sell | 13,000 | $12.74 | $166K | Direct | Nov 16, 2022 (2d) |
| Nov 8, 2022 | AXGN | ↓ Sell | 13,000 | $12.50 | $163K | Direct | Nov 10, 2022 (2d) |
| Aug 10, 2022 | AXGN | ↓ Sell | 8,886 | $9.70 | $86K | Direct | Aug 11, 2022 (1d) |
| Aug 8, 2022 | AXGN | ↓ Sell | 37,046 | $10.54 | $391K | Direct | Aug 8, 2022 (0d) |
| Jun 15, 2021 | PDSB | ↑ Buy | 5,882 | $8.50 | $50K | Direct | Jun 17, 2021 (2d) |
| Feb 25, 2021 | AXGN | ↓ Sell10b5-1 | 24,000 | $22.06 | $529K | Direct | Mar 1, 2021 (4d) |
| Dec 29, 2020 | AXGN | ↓ Sell | 916 | $17.81 | $16K | Direct | Dec 30, 2020 (1d) |
| Dec 21, 2020 | AXGN | ↓ Sell | 379 | $16.42 | $6K | Direct | Dec 22, 2020 (1d) |
| Nov 30, 2018 | AXGN | ↓ Sell10b5-1 | 45,000 | $33.00 | $1.5M | Direct | Dec 4, 2018 (4d) |
| Nov 15, 2018 | AXGN | ↓ Sell | 20,000 | $32.25 | $645K | Direct | Nov 15, 2018 (0d) |
| Jun 3, 2014 | AXGN | ↑ Buy | 5,200 | $2.45 | $13K | Direct | Jun 4, 2014 (1d) |
| Aug 14, 2013 | AXGN | ↑ Buy | 8,334 | $3.00 | $25K | Direct | Aug 15, 2013 (1d) |
| Dec 30, 2011 | AXGN | ↑ Buy | 9,318 | $2.40 | $22K | Direct | Jan 3, 2012 (4d) |
| Nov 22, 2011 | AXGN | ↑ Buy | 15,000 | $2.91 | $44K | Direct | Nov 23, 2011 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Gregory Gene Freitag's insider trades
Gregory Gene Freitag is an insider at PDS Biotechnology (PDSB). Since Nov 22, 2011, Gregory has reported 6 open-market purchases worth $179K and 12 sales worth $4.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
2 sales (49% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (35 filings), option exercises (14 filings), shares withheld for taxes (9 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PDSB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.